State Experts to Discuss New Jersey’s Fentanyl Crisis

PDFNJ and New Jersey Attorney General’s Office to Host 7th Webinar of 2022

Millburn, NJ, June 22, 2022 (GLOBE NEWSWIRE) — MILLBURN — Medical and law enforcement officials will examine the impact of fentanyl on New
Jersey’s opioid epidemic in upcoming Knock Out Opioid Abuse Day learning series webinar, featured
by the Partnership for a Drug-Free New Jersey (PDFNJ) and the New Jersey Coordinator’s Office
Addiction Responses and Enforcement Strategies (NJ CARES), which is responsible for overseeing
drug addiction efforts across the New Jersey Attorney General’s office.
The webinar, “Fentanyl: What You Need to Know Today,” will be held at 11 a.m. on Tuesday, June 28.
presentation will feature Dr. Mehruba Anwar Parris, a board-certified emergency physician and physician
toxicologist at Rutgers University New Jersey Medical School, University Hospital and NJ Poison
information and education system; Drug Enforcement Special Agent Timothy P. McMahon
Administration (DEA) – New Jersey Division; and Marlon Williams, forensic epidemiologist at
DEA New York/New Jersey High Intensity Drug Trafficking Area (HIDTA) and Office of the Chief
New Jersey State Medical Examiner.

Fentanyl is a synthetic opioid prescribed for severe pain that is approximately 50 times stronger than heroin and
100 times more potent than morphine. It has become the leading cause of drug overdose death and has
been at the root of the opioid epidemic in recent years. Synthetic opioids, primarily fentanyl, accounted for
more than 60% of the nearly 92,000 drug overdose deaths in the United States in 2020, the most
recent year
“An opioid epidemic that has ravaged New Jersey and the country for the past two decades has been greatly
exacerbated by the emergence of fentanyl in recent years,” Angelo, Executive Director of PDFNJ
Valentine said. “While deaths from prescription opioids and heroin have declined or plateaued over the past five
years, the number of deaths attributed to fentanyl has exploded. This webinar will provide essential information
information about fentanyl and provide needed information about what New Jersey residents and communities
can do to combat this continuing crisis.
This webinar will be the seventh in the Knock Out Opioid Abuse Day 2022 learning series. In 2021,
PDFNJ and NJ CARES have collaborated on 10 webinars as part of the series. Organizations first
combined efforts on the series in 2020 as a strategy to provide education about the opioid crisis amid
of the COVID-19 pandemic.
The series is an offshoot of Knock Out Opioid Abuse Day, held in New Jersey on October 6.
every year since 2016. The one-day statewide initiative is hosted by PDFNJ and The Community
Coalition for a Safe & Healthy Morris, in cooperation with the New Jersey Division of Mental Health and
Addiction Services and Governor’s Council on Alcoholism and Drug Addiction. The purpose of the day is to
mobilize prevention and treatment communities, community leaders and concerned citizens to
awareness of the potential for addiction to prescribed painkillers, as well as their connection to heroin and
fentanyl use in the state.
In 2021, more than 3,000 people in New Jersey died from suspected drug overdoses, the vast majority of them
which involved some form of opioid, including prescription painkillers, heroin, and synthetic opioids, such as
than fentanyl.
The next webinar, “The Role of Medications in Opioid Use Disorder in Addressing the Opioid Crisis”,
will take place at 11 a.m. on Thursday, July 14. To learn more about Knock Out Opioid Abuse Day and to
to register for this and future webinars, please visit knockoutday.drugfreenj.org.

###

Partnership for a Drug-Free New Jersey: Best known for its statewide substance use prevention advertising
campaign, the Partnership for a Drug-Free New Jersey is a private, nonprofit coalition of drug professionals.
communications, business and government communities whose collective mission is to reduce the demand for illicit products
drugs in New Jersey through media communication. To date, over $200 million in broadcast and print time
space was given to The Partnership’s New Jersey Campaign, making it the largest public service advertisement
campaign in New Jersey history. Since its creation, the Partnership has collected 211 advertising and public messages
national, regional and national media organization relations awards.

CONTACT: Natalie Golub Partnership for a Drug-Free New Jersey 9733824560 natalie@drugfreenj.org

>

Leave a Comment